NPS PHARMACEUTICALS INC 4
4 · NPS PHARMACEUTICALS INC · Filed Feb 14, 2014
Insider Transaction Report
Form 4
STRATEMEIER ED
SVP & Acting GC
Transactions
- Exercise/Conversion
Common Stock
2014-02-13+5,670→ 46,204 total - Tax Payment
Common Stock
2014-02-13$38.30/sh−1,951$74,723→ 44,253 total - Exercise/Conversion
Restricted Stock Units
2014-02-13−5,670→ 11,341 totalExercise: $0.00→ Common Stock (5,670 underlying)
Footnotes (3)
- [F1]Each vested Restricted Stock Unit is the economic equivalent of one share of common stock of NPS Pharmaceuticals, Inc. (the "Issuer"). The vested Restricted Stock Units were settled for shares of the Issuer's common stock.
- [F2]Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to statisfy tax obligations arising from the vesting of the Restricted Stock Units described in this Form 4.
- [F3]On February 13, 2013, the Restricted Stock Units were granted with one third vesting on the first anniversary of the date of grant, one third vesting on the second anniversary of the date of grant and the remaining vesting on the third anniversary of the date of grant. As of the date of this filing, 5,670 of the Restricted Stock Units have vested.